Regeneron Company Updates |

Company Updates

  • We are using our end-to-end antibody technologies to discover and develop brand new therapeutic antibodies for this disease. Our new COVID-19 drug candidate will be studied for its potential both to prevent infection and to treat people already infected with the virus.

Work at Regeneron? Share Your Experiences

Click to Rate